Defining safe thresholds for risk-adapted surveillance after liver transplantation for hepatocellular carcinoma
Widely used models can identify patients suitable for reduced surveillance, though none delineated a true "no-screening" group.
Authors
- Rodrigo Vieira Motta (ORCID: https://orcid.org/0000-0002-6633-9133)
- Elodie Bomfim Hyppólito (ORCID: https://orcid.org/0000-0002-6622-6585)
- Gustavo Coelho (ORCID: https://orcid.org/0000-0003-0845-2864)
- Clébia Azevedo de Lima (ORCID: https://orcid.org/0000-0002-7762-7149)
- Gérard Chollet (ORCID: https://orcid.org/0000-0003-4245-146X)
- Paulo Everton Garcia Costa (ORCID: https://orcid.org/0000-0001-6589-1957)
- Danilo Viana (ORCID: https://orcid.org/0009-0004-1740-915X)
- Pedro Robson Costa Passos
- Angel Evangelista Barroso Magalhães (ORCID: https://orcid.org/0009-0008-7214-3496)
- José Huygens Parente Garcia
- Bartolomeu Alves Neto
Institutions
- Universidade Federal do Ceará (BR)
- University of Oxford (GB)
- Hospital Universitário Walter Cantídio (BR)
Publication Details
- Journal
- Digestive and Liver Disease
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1016/j.dld.2025.12.021
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00